Lanean...
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies
As global health services respond to the coronavirus pandemic, many prescribers are turning to experimental drugs. This review aims to assess the risk of drug–drug interactions in the severely ill COVID-19 patient. Experimental therapies were identified by searching ClinicalTrials.gov for ‘COVID-19’...
Gorde:
| Argitaratua izan da: | J Antimicrob Chemother |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7454591/ https://ncbi.nlm.nih.gov/pubmed/32750131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa340 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|